Table 2. The Spearman's correlation analyses between study variables in diabetic and diabetic retinopathy patients.
|
Diabetes mellitus |
Spearman's correlation |
Diabetic retinopathy |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dis.Dur | FPG | A1C | Alb | IMA | cIMA | GSH | Variables | GSH | cIMA | IMA | Alb | A1C | FPG | Dis.Dur |
| −0.07 | −0.43 | −0.45 | −0.26 | −0.28 | −0.05 | 0.36 | AGE | −0.13 | 0.35 | 0.34 | −0.24 | 0.21 | 0.22 | 0.36 |
| 0.79 | 0.09 | 0.08 | 0.31 | 0.29 | 0.85 | 0.16 | 0.60 | 0.18 | 0.15 | 0.32 | 0.40 | 0.37 | 0.13 | |
| 0.26 | 0.66 | −0.01 | 0.09 | 0.08 | −0.23 | Dis.Dur | −0.31 | 0.68 | −0.73 | −0.18 | 0.64 | 0.56 | ||
| 0.32 | 0.005* | 0.96 | 0.74 | 0.76 | 0.37 | 0.19 | 0.002* | 0.001* | 0.45 | 0.004* | 0.01* | |||
| 0.57 | 0.18 | 0.60 | 0.41 | −0.26 | FPG | −0.52 | 0.72 | 0.74 | −0.26 | 0.50 | ||||
| 0.02* | 0.48 | 0.01* | 0.11 | 0.32 | 0.02* | 0.001* | 0.001* | 0.28 | 0.03* | |||||
| 0.16 | 0.55 | 0.43 | −0.24 | A1C | −0.37 | 0.52 | 0.70 | 0.03 | ||||||
| 0.54 | 0.02* | 0.09 | 0.36 | 0.12 | 0.02* | 0.001* | 0.88 | |||||||
| −0.01 | −0.36 | −0.31 | Alb | 0.16 | −0.53 | −0.19 | ||||||||
| 0.95 | 0.16 | 0.23 | 0.50 | 0.07 | 0.43 | |||||||||
| 0.89 | −0.50 | IMA | −0.49 | 0.87 | ||||||||||
| 0.00* | 0.04* | 0.03* | 0.00* | |||||||||||
| −0.30 | cIMA | −0.48 | ||||||||||||
| 0.25 | 0.04* | |||||||||||||
Abbreviations: A1C, glycated hemoglobin; Alb, albumin; cIMA, corrected IMA for albumin levels; Dis.Dur, duration of disease; FPG, fasting plasma glucose; GSH, reduced glutathione; IMA, ischemia modified albumin.
Non-highlighted, non-italic numbers are correlation coefficient (r) values. Highlighted, italic numbers are statistical significance (P) values, *P<0.05.